These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1857888)

  • 21. Nurses and emesis induced by cancer therapy.
    Dulfer S
    Nurs RSA; 1991 Mar; 6(3):9-11, 14. PubMed ID: 2046739
    [No Abstract]   [Full Text] [Related]  

  • 22. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.
    Shankar A; Roy S; Malik A; Julka PK; Rath GK
    Asian Pac J Cancer Prev; 2015; 16(15):6207-13. PubMed ID: 26434818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus regarding multiple day and rescue antiemetic therapy.
    De Mulder PH; Roila F; Kris MG; Marty MM
    Support Care Cancer; 1998 May; 6(3):248-52. PubMed ID: 9629878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Navoban--the new 5HT3-antagonist].
    Internist (Berl); 1994 May; 35(5 Suppl):1-8. PubMed ID: 9209536
    [No Abstract]   [Full Text] [Related]  

  • 26. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tropisetron (Navoban): just another "setron"?
    Aapro MS
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):1-2. PubMed ID: 9113118
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with the clinical use of navoban].
    Voznyĭ EK; Dobrovol'skaia NI; Volkova LA
    Vopr Onkol; 1995; 41(1):70-1. PubMed ID: 7667947
    [No Abstract]   [Full Text] [Related]  

  • 29. An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting.
    Jantunen IT; Kataja VV; Muhonen TT
    Eur J Cancer; 1997 Jan; 33(1):66-74. PubMed ID: 9071902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Trigg ME; Higa GM
    J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention and therapy of cytostatic-induced vomiting].
    Riess H; Ludat K
    Dtsch Med Wochenschr; 1991 May; 116(18):705-12. PubMed ID: 2026101
    [No Abstract]   [Full Text] [Related]  

  • 32. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
    Perez EA
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):1-2. PubMed ID: 7570049
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).
    Roila F; Warr D; Aapro M; Clark-Snow RA; Einhorn L; Gralla RJ; Herrstedt J; Saito M; Tonato M
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S57-62. PubMed ID: 21132332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma.
    Lee CY; Ratnapalan S; Thompson M; Nathan PC; Closs J; French A; Punnett A; Garcia-Bournissen F; Ito S; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e1-4. PubMed ID: 20051608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Hartvig P
    J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570
    [No Abstract]   [Full Text] [Related]  

  • 36. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis in patients with testicular tumours treated with chemotherapy.
    van den Berkmortel F; de Wit R; de Rooy J; DeMulder P
    Neth J Med; 2004 Jan; 62(1):23-7. PubMed ID: 15061230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of neurokinin-1 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy.
    Rogers MP; Blackburn L
    Clin J Oncol Nurs; 2010 Aug; 14(4):500-4. PubMed ID: 20682506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.
    Hesketh P
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):19-23. PubMed ID: 7570050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.